平安健康(检测)中心获“2019中国健康产业商业模式创新奖” 董事长方蔚豪获评健康中国形象大使称号

2019-08-27 梅斯医学 梅斯医学

8月24日-25日,由中国管理科学研究院新兴经济产业研究所、中国国际经济技术合作促进会、健康科技工作委员会、中国民族医药协会健康科普分会主办的“2019中国健康产业大会”在北京举办。国家政府领导、医疗健康产业专家学者、行业翘楚等来自全国各地上千位业界精英出席会议,共同推动和见证健康产业的新趋势、新未来。会上,平安医疗健康管理股份有限公司联席董事长兼CEO、平安国际融资租赁有限公司董事长兼CEO、平

8月24日-25日,由中国管理科学研究院新兴经济产业研究所、中国国际经济技术合作促进会、健康科技工作委员会、中国民族医药协会健康科普分会主办的“2019中国健康产业大会”在北京举办。国家政府领导、医疗健康产业专家学者、行业翘楚等来自全国各地上千位业界精英出席会议,共同推动和见证健康产业的新趋势、新未来。



会上,平安医疗健康管理股份有限公司联席董事长兼CEO、平安国际融资租赁有限公司董事长兼CEO、平安好医投资管理有限公司董事长方蔚豪获评“健康中国形象大使”。 平安好医投资管理有限公司总经理江颖荣获“2019中国健康投资产业年度十大领军人物”奖。平安集团旗下平安健康(检测)中心凭借其在医疗健康行业的模式创新实践引领社会第三方医疗蓬勃发展,获“2019中国健康产业商业模式创新奖”





整合优质医疗资源,构建医疗健康生态

在我国持续深化医疗改革、去产能的政策下,随着人口老龄化加剧,居民卫生意识增强,为解决看病难看病贵问题,国家陆续出台多项政策鼓励社会资本办医。

为积极响应国家政策,平安集团通过“金融+科技”双轮驱动,打造“医疗生态圈”,在医疗服务端投资设立平安健康(检测)中心,以“影像诊断+医学检验+精密检查”的多业态融合为抓手,整合高端设备、前沿技术和权威专家等核心资源,形成线上与线下相结合的创新医疗服务闭环,从而促进优质医疗资源的共建共享,助推大健康产业的稳定发展。

目前,公司已在全国落地超过330家检测中心,覆盖27个省,未来计划5年内投资300亿,在全国建立1000家检测中心,打造医疗领域的共享经济。社会办医的长远发展有赖于资金、客户来源,以及与支付端的连接。平安健康(检测)中心与集团内平安医保科技、平安好医生、平安健康险、平安智慧城市旗下智慧医疗等紧密连接,有效地打通三者形成的闭环,共同为所有医疗资源的入口提供服务。

方蔚豪表示,“平安健康(检测)中心拥有数百位医疗领域各界资深人士,对医疗行业有着透彻的理解和洞见,借助集团多年积累的独特优势,平安能够更加了解医生、医院、患者之间的关系。”



布局医疗科技创新,盘活医疗资源潜力

本次大会以“健康中国战略与科技成就健康未来”为主题,中国平安聚焦“金融+科技”,通过科技赋能精准诊断,助力医疗模式升级。

伴随心脑血管、癌症等重大疾病发病率的持续增长且呈年轻化的趋势,不断升级的疾病防治周期的需求,以及优质医疗资源下沉的需求日益凸显。平安健康(检测)中心通过强化在医疗质量、科技研发、模式创新等方面的投入,加速推进技术创新,以“影像云”、“影像AI”、“人脸识别”等创新尖端科技提升诊断质量和效率,并自主研发“平安好影像”智慧云平台,通过云技术的应用,实现了安全、高效的远程阅片,搭建区域医疗服务网络。

平安健康(检测)中心在业务不断突破的同时,积极推进国际化战略,现已与国际领先的日本Miraca集团旗下SRL公司共同设立平安好医医学检验实验室合资公司。以“日本技术、中国收费”为特色,引进SRL顶尖的检验技术、丰富的检验项目、先进的质控体系以及优秀的行业专家,并在全国布局医学检验实验室,建立第三方医学检验行业金标准,对于提升临床诊疗效果和区域医疗服务能力具有重要的实践意义。



平安健康(检测)中心积极与行业伙伴深度合作,整合多方优势资源,为合作伙伴提供多元化的“医疗+健康”解决方案,也为医疗健康行业探索成熟商业模式提供了重要启示,致力于成为中国第三方健康检测行业的领导者。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1741098, encodeId=149a1e4109879, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sun Jul 26 21:01:00 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769241, encodeId=f7301e6924184, content=<a href='/topic/show?id=aad14885340' target=_blank style='color:#2F92EE;'>#平安健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48853, encryptionId=aad14885340, topicName=平安健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea0e37999606, createdName=xinmeili, createdTime=Sat Aug 01 17:01:00 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771799, encodeId=259b1e7179915, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Fri Dec 06 15:01:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969192, encodeId=3f9c1969192fc, content=<a href='/topic/show?id=af99882909c' target=_blank style='color:#2F92EE;'>#董事长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88290, encryptionId=af99882909c, topicName=董事长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Sep 17 01:01:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285773, encodeId=84331285e7318, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu Aug 29 08:01:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599424, encodeId=9040159942404, content=<a href='/topic/show?id=08c14006ead' target=_blank style='color:#2F92EE;'>#商业模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40067, encryptionId=08c14006ead, topicName=商业模式)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fdc18711141, createdName=lqrandywkz, createdTime=Thu Aug 29 08:01:00 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1741098, encodeId=149a1e4109879, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sun Jul 26 21:01:00 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769241, encodeId=f7301e6924184, content=<a href='/topic/show?id=aad14885340' target=_blank style='color:#2F92EE;'>#平安健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48853, encryptionId=aad14885340, topicName=平安健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea0e37999606, createdName=xinmeili, createdTime=Sat Aug 01 17:01:00 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771799, encodeId=259b1e7179915, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Fri Dec 06 15:01:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969192, encodeId=3f9c1969192fc, content=<a href='/topic/show?id=af99882909c' target=_blank style='color:#2F92EE;'>#董事长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88290, encryptionId=af99882909c, topicName=董事长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Sep 17 01:01:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285773, encodeId=84331285e7318, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu Aug 29 08:01:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599424, encodeId=9040159942404, content=<a href='/topic/show?id=08c14006ead' target=_blank style='color:#2F92EE;'>#商业模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40067, encryptionId=08c14006ead, topicName=商业模式)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fdc18711141, createdName=lqrandywkz, createdTime=Thu Aug 29 08:01:00 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1741098, encodeId=149a1e4109879, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sun Jul 26 21:01:00 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769241, encodeId=f7301e6924184, content=<a href='/topic/show?id=aad14885340' target=_blank style='color:#2F92EE;'>#平安健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48853, encryptionId=aad14885340, topicName=平安健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea0e37999606, createdName=xinmeili, createdTime=Sat Aug 01 17:01:00 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771799, encodeId=259b1e7179915, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Fri Dec 06 15:01:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969192, encodeId=3f9c1969192fc, content=<a href='/topic/show?id=af99882909c' target=_blank style='color:#2F92EE;'>#董事长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88290, encryptionId=af99882909c, topicName=董事长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Sep 17 01:01:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285773, encodeId=84331285e7318, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu Aug 29 08:01:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599424, encodeId=9040159942404, content=<a href='/topic/show?id=08c14006ead' target=_blank style='color:#2F92EE;'>#商业模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40067, encryptionId=08c14006ead, topicName=商业模式)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fdc18711141, createdName=lqrandywkz, createdTime=Thu Aug 29 08:01:00 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1741098, encodeId=149a1e4109879, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sun Jul 26 21:01:00 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769241, encodeId=f7301e6924184, content=<a href='/topic/show?id=aad14885340' target=_blank style='color:#2F92EE;'>#平安健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48853, encryptionId=aad14885340, topicName=平安健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea0e37999606, createdName=xinmeili, createdTime=Sat Aug 01 17:01:00 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771799, encodeId=259b1e7179915, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Fri Dec 06 15:01:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969192, encodeId=3f9c1969192fc, content=<a href='/topic/show?id=af99882909c' target=_blank style='color:#2F92EE;'>#董事长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88290, encryptionId=af99882909c, topicName=董事长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Sep 17 01:01:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285773, encodeId=84331285e7318, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu Aug 29 08:01:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599424, encodeId=9040159942404, content=<a href='/topic/show?id=08c14006ead' target=_blank style='color:#2F92EE;'>#商业模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40067, encryptionId=08c14006ead, topicName=商业模式)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fdc18711141, createdName=lqrandywkz, createdTime=Thu Aug 29 08:01:00 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1741098, encodeId=149a1e4109879, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sun Jul 26 21:01:00 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769241, encodeId=f7301e6924184, content=<a href='/topic/show?id=aad14885340' target=_blank style='color:#2F92EE;'>#平安健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48853, encryptionId=aad14885340, topicName=平安健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea0e37999606, createdName=xinmeili, createdTime=Sat Aug 01 17:01:00 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771799, encodeId=259b1e7179915, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Fri Dec 06 15:01:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969192, encodeId=3f9c1969192fc, content=<a href='/topic/show?id=af99882909c' target=_blank style='color:#2F92EE;'>#董事长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88290, encryptionId=af99882909c, topicName=董事长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Sep 17 01:01:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285773, encodeId=84331285e7318, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu Aug 29 08:01:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599424, encodeId=9040159942404, content=<a href='/topic/show?id=08c14006ead' target=_blank style='color:#2F92EE;'>#商业模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40067, encryptionId=08c14006ead, topicName=商业模式)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fdc18711141, createdName=lqrandywkz, createdTime=Thu Aug 29 08:01:00 CST 2019, time=2019-08-29, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1741098, encodeId=149a1e4109879, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Sun Jul 26 21:01:00 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1769241, encodeId=f7301e6924184, content=<a href='/topic/show?id=aad14885340' target=_blank style='color:#2F92EE;'>#平安健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48853, encryptionId=aad14885340, topicName=平安健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea0e37999606, createdName=xinmeili, createdTime=Sat Aug 01 17:01:00 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771799, encodeId=259b1e7179915, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40059, encryptionId=62754005931, topicName=商业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fd6238344589, createdName=zhangxingru, createdTime=Fri Dec 06 15:01:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1969192, encodeId=3f9c1969192fc, content=<a href='/topic/show?id=af99882909c' target=_blank style='color:#2F92EE;'>#董事长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88290, encryptionId=af99882909c, topicName=董事长)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Sep 17 01:01:00 CST 2019, time=2019-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285773, encodeId=84331285e7318, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Thu Aug 29 08:01:00 CST 2019, time=2019-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599424, encodeId=9040159942404, content=<a href='/topic/show?id=08c14006ead' target=_blank style='color:#2F92EE;'>#商业模式#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40067, encryptionId=08c14006ead, topicName=商业模式)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fdc18711141, createdName=lqrandywkz, createdTime=Thu Aug 29 08:01:00 CST 2019, time=2019-08-29, status=1, ipAttribution=)]

相关资讯

曜影医疗联合平安健康正式开启“高品质慢病管理”战略合作

2018年9月 11 日,曜影医疗投资管理有限公司(SinoUnited Health Clinic;以下简称:曜影医疗)与平安健康保险股份有限公司(以下简称:平安健康)正式签署战略合作协议,为平安健康保险股份有限公司的客户共同提供高品质慢病管理服务,包括高血压、高脂血症和糖尿病等。双方旨在通过系统性的慢病管理流程、多种形式的患者教育、主诊医生标准化方案、定期随访等线上和线下模式,整合双方资源